Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32,055 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: SAGES guidelines for the management of comorbidities relevant to metabolic and bariatric surgery.
Kumar SS, Wunker C, Collings A, Bansal V, Zoumpou T, Chang J, Rodriguez N, Sabour A, Hilton LR, Ghanem OM, Kushner BS, Loss LJ, Aleassa EM, Haskins IN, Ayloo S, Reid A, Overby DW, Hallowell P, Kindel TL, Slater BJ, Palazzo F. Kumar SS, et al. Surg Endosc. 2025 Jan 13. doi: 10.1007/s00464-025-11537-3. Online ahead of print. Surg Endosc. 2025. PMID: 39806183 No abstract available.
Assessing the Efficacy of Farnesoid X Receptor Agonists in the Management of Metabolic Dysfunction-associated Steatotic Liver Disease: A Systematic Review and Meta-analysis: Efficacy of Farnesoid X Receptor Agonists in Metabolic Dysfunction-associated Steatotic Liver Disease: Systematic Review and Meta-analysis.
Kumar J, Hasan M, Mohsin S, Nagar T, Jamil A, Ahmed A, Krishna VL, Kumar S. Kumar J, et al. Among authors: kumar s. Clin Res Hepatol Gastroenterol. 2025 Jan 11:102530. doi: 10.1016/j.clinre.2025.102530. Online ahead of print. Clin Res Hepatol Gastroenterol. 2025. PMID: 39805519
Five-Year Results With Patisiran for Hereditary Transthyretin Amyloidosis With Polyneuropathy: A Randomized Clinical Trial With Open-Label Extension.
Adams D, Wixner J, Polydefkis M, Berk JL, Conceição IM, Dispenzieri A, Peltier A, Ueda M, Bender S, Capocelli K, Jay PY, Yureneva E, Obici L; patisiran Global OLE study group. Adams D, et al. JAMA Neurol. 2025 Jan 13. doi: 10.1001/jamaneurol.2024.4631. Online ahead of print. JAMA Neurol. 2025. PMID: 39804640
32,055 results
You have reached the last available page of results. Please see the User Guide for more information.